Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ZD-1839, an EGFR-TK inhibitor worthy of further testing

June 23, 1998

Aphton and SmithKline Beecham form alliance for Gonadimmune

June 22, 1998

SB-T-101131, a second-generation taxane with improved efficacy in MDR tumors

June 22, 1998

Immunex awarded gene patent on TRAIL molecule

June 22, 1998

L-NDDP, a liposomal cisplatin derivative in phase II testing

June 22, 1998

Combretastatin potentiates antitumor efficacy of chemo- and radiotherapy in preclinical studies

June 22, 1998

BBR-3438, a promising new agent for prostate cancer

June 22, 1998

Lilly's oral diarylsulfonylurea LY-295501 profiled at NCI-EORTC meeting

June 22, 1998

Targretin found to cause regression of tamoxifen-resistant breast cancer tumors

June 22, 1998

Bay-12-9566: a promising anticancer compound progresses to phase III at Bayer

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...